This infographic provides an illustration through the current manual process of the up front process of revenue cycle versus the automation process path. Through the journey you are able to visualize the reduction in manual labor to your current manual process to see the impact it would make on your staff, the improvement in price transparency to patients, and increasing collections at the point of service. Leverage price transparency at the point of service to improve the patient experience. Leverage collection opportunities at the point of service Reduce manual labor on administrative paperwork Focus on the work that matters, providing… Read entire article here
The US finds itself woefully unprepared to perform enough COVID-19 testing to identify and quarantine infected patients at scale, slowed by test development regulations; a disbanded White House pandemic response team; and a lack of coordination between local, state and federal governments. This lack of “systemness” in the healthcare system has left clinical laboratories scrambling to receive testing approval from the Centers for Disease Control (CDC) and ramp up production. Fortunately, testing guidelines were loosened by the Federal Drug Administration (FDA) at the end of February, allowing academic labs and large commercial labs like Quest Diagnostics and LabCorp to quickly… Read entire article here
The 21st Century Cures Act and its Impact on Health IT Some important healthcare legislation was passed early last week that you might have missed, but which has even more relevance given the significant care coordination challenges in dealing with the COVID-19 outbreak, testing, and quarantine requirements. The Office of the National Coordinator for Health Information Technology (ONC) passed the Cures Act Final Rule, which is designed to provide patients and providers secure access to health information. Meanwhile, the Centers for Medicare & Medicaid Services (CMS) passed the CMS Interoperability and Patient Access Final Rule, which is designed to provide… Read entire article here
Last week, we participated in the Diagnostic Coverage and Reimbursement Conference in San Diego. It was an intimate gathering that brought together executives from diagnostics and genomics laboratories, and payers to openly discuss reimbursement, market access, and revenue cycle challenges and what can be done to address them. The two topics that permeated most discussions were prior authorization and price transparency. Prior Authorization There was consensus among all attendees that the increase in prior authorization requests has been problematic and that providers and payers need to work collaboratively to improve adoption, reduce physician abrasion and — most importantly — provide… Read entire article here
